Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 28

Related Articles by Review for PubMed (Select 18425044)

1.

BD ProEx C: a sensitive and specific marker of HPV-associated squamous lesions of the cervix.

Badr RE, Walts AE, Chung F, Bose S.

Am J Surg Pathol. 2008 Jun;32(6):899-906. doi: 10.1097/PAS.0b013e31815bbb69.

PMID:
18425044
2.

p16 expression in the female genital tract and its value in diagnosis.

O'Neill CJ, McCluggage WG.

Adv Anat Pathol. 2006 Jan;13(1):8-15. Review.

PMID:
16462152
3.

Efficiency of immunohistochemical p16 expression and HPV typing in cervical squamous intraepithelial lesion grading and review of the p16 literature.

Yildiz IZ, Usubütün A, Firat P, Ayhan A, Küçükali T.

Pathol Res Pract. 2007;203(6):445-9. Epub 2007 May 31. Review.

PMID:
17543474
4.

Diagnostic utility of p16INK4a: a reappraisal of its use in cervical biopsies.

Mulvany NJ, Allen DG, Wilson SM.

Pathology. 2008 Jun;40(4):335-44. doi: 10.1080/00313020802035907. Review.

PMID:
18446622
5.
6.

Histology of cervical intraepithelial neoplasia and the role of biomarkers.

Martin CM, O'Leary JJ.

Best Pract Res Clin Obstet Gynaecol. 2011 Oct;25(5):605-15. doi: 10.1016/j.bpobgyn.2011.04.005. Epub 2011 Jun 1. Review.

PMID:
21636328
7.

P16INK4a immunocytochemistry/immunohistochemistry: need for scoring uniformization to be clinically useful in gynecological pathology.

van Bogaert LJ.

Ann Diagn Pathol. 2012 Oct;16(5):422-6. doi: 10.1016/j.anndiagpath.2012.03.006. Epub 2012 Apr 24. Review.

PMID:
22537665
8.
10.

Functional biomarkers in cervical precancer: an overview.

Gupta N, Srinivasan R, Rajwanshi A.

Diagn Cytopathol. 2010 Aug;38(8):618-23. doi: 10.1002/dc.21270. Review.

PMID:
19941372
11.

Redefining early cervical neoplasia: recent progress.

Nucci MR, Crum CP.

Adv Anat Pathol. 2007 Jan;14(1):1-10. Review.

PMID:
17198305
12.

Analysis of telomerase as a diagnostic biomarker of cervical dysplasia and carcinoma.

Jarboe EA, Liaw KL, Thompson LC, Heinz DE, Baker PL, McGregor JA, Dunn T, Woods JE, Shroyer KR.

Oncogene. 2002 Jan 21;21(4):664-73. Review.

13.

In vivo and in vitro "markers" of human cervical intraepithelial neoplasia.

Wilbanks GD.

Cancer Res. 1976 Jul;36(7 PT 2):2485-94. Review.

14.

Molecular markers for the prediction of progression of CIN lesions.

Gray LJ, Herrington CS.

Int J Gynecol Pathol. 2004 Apr;23(2):95-6. Review. No abstract available.

PMID:
15084835
15.
16.

[Metaplasia and high grade CIN. Diagnostic difficulties].

Tranbaloc P.

Gynecol Obstet Fertil. 2002 Nov;30(11):845-9. Review. French.

PMID:
12476688
17.

Role of hormone cofactors in the human papillomavirus-induced carcinogenesis of the uterine cervix.

Delvenne P, Herman L, Kholod N, Caberg JH, Herfs M, Boniver J, Jacobs N, Hubert P.

Mol Cell Endocrinol. 2007 Jan 29;264(1-2):1-5. Epub 2006 Dec 4. Review.

PMID:
17145130
18.

Immunohistochemistry as a diagnostic aid in cervical pathology.

McCluggage WG.

Pathology. 2007 Feb;39(1):97-111. Review.

PMID:
17365826
19.

Benign and malignant pathology of the cervix, including screening.

Liao SY, Manetta A.

Curr Opin Obstet Gynecol. 1993 Aug;5(4):497-503. Review.

PMID:
8400047
20.

[Interest of new biomarkers in cervical precancerous lesion management].

Dachez R.

J Gynecol Obstet Biol Reprod (Paris). 2008 Feb;37 Suppl 1:S152-4. doi: 10.1016/j.jgyn.2007.11.023. Epub 2008 Jan 11. Review. French.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk